| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0010174> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0010181> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0010187> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0024870> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0033105> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0033145> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0035736> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0036375> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0036530> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0036667> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0036668> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0037791> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0086067> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0150099> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C0220908> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C1511536> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C2718036> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C2718037> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C3853051> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C3853052> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C5244026> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C5392966> <https://research.tib.eu/covid-19/entity/33764982_HAS_TOPIC_C5392967>
?:authorAffiliation	[\'OptumLabs, UnitedHealth Group, Minnetonka, MN, United States of America.\', \'Division of Infectious Diseases, Department of Medicine, Columbia University, New York, NY, United States of America.\', \'ProHealth Care, Optum, Lake Success, NY, United States of America.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Berke_Ethan_M> <https://research.tib.eu/covid-19/entity/Griffin_Daniel_O> <https://research.tib.eu/covid-19/entity/Kennedy_Caleb_J> <https://research.tib.eu/covid-19/entity/Lyng_Gregory_D> <https://research.tib.eu/covid-19/entity/Sheils_Natalie_E>
?:doi	10.1371/journal.pone.0248783
?:doi	<https://research.tib.eu/covid-19/entity/10.1371/journal.pone.0248783>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	PloS one
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33764982>
?:pmid	<https://research.tib.eu/covid-19/entity/33764982>
?:pmid	33764982
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.164
?:rankingScore_hIndex	241
?:title	Identifying optimal COVID-19 testing strategies for schools and businesses: Balancing testing frequency, individual test technology, and cost.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33764982>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33764982>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all